
- Past
- 20/01/2026 15:00 Europe/Brussels
The Alpha webinar series explores the benefits of Targeted Alpha Therapy (TAT) for cancer, featuring renowned speakers sharing their insights and expertise. In this first webinar, our two experts will delve into TAT distinctive radiobiological effects, its relevance for cancer care as well as the early experience and clinical progress in the field.
This webinar is already ready over. Missed the live webinar or want to rewatch it?
Speakers
Speakers
Prof Dr Jean-Pierre Pouget, PhDResearch Director, Team LeaderINSERM
Prof Dr Alfred MorgensternHead of DG Joint ResearchEuropean Commission- Topics
Radiobiology of Alpha Particles: Harnessing its unique power for Cancer Treatment
Charting Progress in Alpha Particle Therapy : from Early Experience to where we are today

